KRAS G13D + BRAF mutation
|
Melanoma
|
KRAS G13D + BRAF mutation
|
Melanoma
|
vemurafenib Resistant: D – Preclinical
|
vemurafenib Resistant: D – Preclinical
|
KRAS G13D + BRAF mutation
|
CRC
|
KRAS G13D + BRAF mutation
|
CRC
|
trametinib Resistant: D – Preclinical
|
trametinib Resistant: D – Preclinical
|